Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Understanding psychiatric disorders through functional brain imaging.

Clinton D Kilts1

  • 1Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, 30322, USA. sdpcdk@emory.edu

Psychopharmacology Bulletin
|July 28, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lessons learned: A neuroimaging research center's transition to open and reproducible science.

Frontiers in big data·2022
Same author

Action-value processing underlies the role of the dorsal anterior cingulate cortex in performance monitoring during self-regulation of affect.

PloS one·2022
Same author

A test of affect processing bias in response to affect regulation.

PloS one·2022
Same author

L-DOPA and consolidation of fear extinction learning among women with posttraumatic stress disorder.

Translational psychiatry·2020
Same author

Erratum to "Synthesis, F-18 radiolabeling, and microPET evaluation of 3-(2,4-dichlorophenyl)-N-alkyl-N-fluoroalkyl-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-amines as ligands of the corticotropin-releasing factor type-1 (CRF1) receptor" [Bioorg. Med. Chem. 23 (2015) 4286-4302].

Bioorganic & medicinal chemistry·2020
Same author

Intertemporal decision-making-related brain states predict adolescent drug abuse intervention responses.

NeuroImage. Clinical·2019
Same journal

Catatonia Associated with Psychosis: A Retrospective Study of 164 Inpatients.

Psychopharmacology bulletin·2026
Same journal

Escitalopram-Induced Spasmodic Torticollis in an Early Psychosis Service: A Case Report.

Psychopharmacology bulletin·2026
Same journal

Beyond Exposure: Standardizing Buprenorphine Training in Pain Medicine Fellowship.

Psychopharmacology bulletin·2026
Same journal

Association of CBC-Derived Indices of Inflammation with Response to Glecaprevir/Pibrentasvir for PTSD.

Psychopharmacology bulletin·2026
Same journal

When Care Becomes Dangerous: Patient Assaults Against Physicians.

Psychopharmacology bulletin·2026
Same journal

Efficacy and Safety of Centanafadine in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Psychopharmacology bulletin·2026
See all related articles

Functional brain imaging, including PET and SPECT, reveals neural changes linked to psychiatric conditions and treatment responses. This technology aids in predicting psychiatric disorder risk and optimizing psychopharmacologic therapies.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Medical Imaging

Background:

  • Functional brain imaging, such as PET and SPECT, measures neural events in psychiatric illness.
  • Psychopharmacologic treatments induce adaptive neural and behavioral changes.

Purpose of the Study:

  • To explore the application of functional neuroimaging in understanding psychiatric disorders.
  • To investigate the visualization of neural receptor and transporter changes after pharmacotherapy.
  • To assess the potential of neuroimaging in identifying at-risk individuals and treatment outcomes.

Main Methods:

  • Utilized functional brain imaging techniques like Positron Emission Tomography (PET) and Single-Photon Emission Tomography (SPECT).
  • Designed studies to visualize changes in neural receptors and transporters.

Related Experiment Videos

  • Examined hemodynamic and metabolic neural events associated with psychiatric conditions and experimental challenges.

    • Main Results:

    • Functional neuroimaging can detect adaptive changes in neural circuitry following psychopharmacologic treatment.
    • The technology offers insights into behavioral changes corresponding to neural alterations.
    • Studies aimed to visualize receptor and transporter modifications post-treatment.

    Conclusions:

    • Functional neuroimaging holds promise for identifying individuals at risk for psychiatric disorders.
    • This technology can differentiate between treatment responders and non-responders.
    • Functional neuroimaging may lead to the discovery of new treatments and novel applications for existing ones.